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Several of the identiﬁed genes such as PTGES and FRZB were previously
found to mark OA in expression analyses and/or genetic association
studies. Remarkably, we identiﬁed several genes which regulate nerve
growth processes to be up-regulated in the OA affected areas. This ﬁnding
raises the question whether increasing pain signals at OA lesions may
confer risk to joint replacement surgery.
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GENETIC POLYMORPHISMS OF TUMOR NECROSIS FACTOR ALPHA GENE
AND SUSCEPTIBILITY TO HAND OSTEOARTHRITIS IN FINNISHWOMEN
S. Ha¨ma¨la¨inen, S. Solovieva, T. Vehmas, P. Leini-Arjas, A. Hirvonen.
Finnish Inst. of Occupational Hlth., Helsinki, Finland
Purpose: Osteoarthritis (OA) is a common disease characterised by
degeneration of the cartilage of synovial joints. Available evidence
suggests that genetic factors may play a major role in the etiology
of OA. Since Tumor necrosis factor alpha (TNFa) has been shown to be
produced more in OA cartilage than in normal cartilage, it is a good
candidate for these genetic factors. We examined this by studying the
role of four single nucleotide polymorphisms (SNPs) (rs1799964 "-1031",
rs1800630 "-863", rs1799724 "-857" and rs1800629 "-308") in TNFa gene
and their haplotypes in the individual susceptibility to hand OA in Finnish
women.
Methods: Bilateral hand radiographs of 543 Finnish female dentists and
teachers aged 45–63 years and living in the Helsinki metropolitan region
were examined and classiﬁed for the presence of OA using a modiﬁed
Kellgren-Lawrence (K-L) system and reference images. Hand OA was
deﬁned as at least mild (K-L > 2) symptomatic distal interphalangeal
(DIP) hand OA in at least 2 ﬁnger joints (symptDIP OA 2+ >2). The
genotypes were determined by PCR-based methods. Data regarding other
risk factors were collected by questionnaire. Association between the
genotypes/haplotypes and hand OA were studied by logistic regression
with SPSS statistical package Version 18.0. Haplotypes were analysed
with Haploview program and reconstructed with PHASE
Results: According to power calculations, this study had 80% power to
detect ORs from 2.7 to 4.0 depending on the minor allele frequency
(6–18%), based on a two-sided alpha of 0.05.
The prevalence of symptDIP OA 2+ >2 was 9%, (6.8% in dentists, 11.7% in
teachers). The genotype frequencies were in Hardy-Weinberg equilibrium
in all studied polymorphic loci. An association was found between the
TNFa −1031 and −863 loci’s minor allele carriage (C-allele in −1031
and A-allele in −863) and symptDIP OA 2+ >2 when adjusted for age,
occupation and BMI. The minor allele in −1031 locus posed a borderline
signiﬁcant risk in total sample (OR 1.76 95% CI 0.95–3.29). When stratiﬁed
by occupation an almost 3-fold risk (OR 2.81, 95% CI 1.06–7.45) was seen
in dentists whereas no statistically signiﬁcant association was seen in
teachers (OR 1.30, 95% CI 0.57–2.95). Similarly, carriage of the minor allele
in −863 locus posed an over 2-fold risk in total sample (OR 2.13, 95% CI
1.14–4.00), and when stratiﬁed by occupation the risk was over 3-fold in
dentists (OR 3.40, 95% CI 1.27–9.13) whereas no statistically signiﬁcant
association was seen in teachers (OR 1.56, 95% CI 0.68–3.56).
Haplotype analyses revealed a LD between the TNFa −1031 and −863 loci
(D’ 1.0; r2 0.86). The most common haplotype was TC (82%), followed by
CA (17%) and CC (2%). The haplotype analysis gave similar results to the
genotype analyses; the CA-haplotype showed association to symptDIP
OA 2+ >2 when adjusted for age, occupation and BMI (OR 1.80 95% CI
1.06–3.08). When stratiﬁed by occupation the dentists had an over 2-fold
risk (OR 2.29 95% CI 1.01–5.20) whereas no signiﬁcant risk was seen in
teachers (OR 1.54 95% CI 0.76–3.13).
Conclusions: Our results suggest that the TNFa gene polymorphisms
may play a role in the etiology of hand OA.
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GENOME-WIDE ASSOCIATION STUDY TO IDENTIFY NEW GENES AND
PATHWAYS CONFERRING RISK TO OA SUSCEPTIBILITY IN MULTIPLE
JOINT LOCATIONS AS DEFINED IN THE GARP STUDY
Y.F. Ramos1, S.D. Bos1, U. Styrkarsdottir2, K. Panoutsopoulou3,
C. Keurentjes4, N. Lakenberg1, R. Nelissen4, M. Kloppenburg5, H. Kroon6,
A. Uitterlinden7,8, J. Loughlin9,3, E. Zeggini3, I. Jonsdottir2, J.B. van
Meurs7,8, P.E. Slagboom1,8, I. Meulenbelt1,8. 1Section of Molecular
Epidemiology, LUMC, Leiden, Netherlands; 2deCODE Genetics, Reykjavik,
Iceland; 3arcOGEN Consortium, Cambridge, United Kingdom; 4Dept. of
Orthopaedics, LUMC, Leiden, Netherlands; 5Dept. of Rheumatology &
Clinical Epidemiology, LUMC, Leiden, Netherlands; 6Dept. of Radiology,
LUMC, Leiden, Netherlands; 7Dept. of Internal Med., Erasmus MC,
Rotterdam, Netherlands; 8The Netherlands Genomics Initiative, NCHA,
Leiden-Rotterdam, Netherlands; 9Newcastle Univ., Musculoskeletal Res.
Group, Newcastle, United Kingdom
Purpose: Identify, by genome wide association (GWAS), common OA
susceptibility loci conferring risk to OA at multiple joint locations as
deﬁned in the GARP study.
Methods: A genome wide scan was performed by applying the
Illumina Human660W in the GARP study (N=380) and random controls
(N=1670). The GARP study consists of sibling pairs with symptomatic
OA at multiple joint locations at relative young age (40–70 yrs). This
relatively severe phenotype with familial background may help to stratify
OA into a genetically homogeneous subset, thereby enhancing power
and allowing identiﬁcation of variants with larger impact. Putative OA
susceptibility loci with P-values≤10−5 were replicated both in silico (3
datasets for multiple joint OA, total N =796 cases and 44088 controls) and
by de novo genotyping (N=400). Pathway analysis was performed with
the top 200 loci of the GARP genome wide scan by applying the Database
for Annotation, Visualization and Integrated Discovery (DAVID).
Results: Our analyses resulted in 3 loci at 6q21 (106 Mb), 7q35 (146 Mb)
and 15q26 (91 Mb) that confer consistent risk to OA at multiple joint
locations with an overall P-value <10−4 in the meta-analysis. Pathway
analysis indicated a signiﬁcant involvement of genes expressed during
development.
Conclusions: Although 3 loci showed consistent association to OA at
multiple joint locations, none passed the genome-wide signiﬁcance level
(P-value <10−8). Further analyses are necessary to conﬁrm whether these
putative loci confer risk to our speciﬁc OA phenotype. In addition, we
would like to investigate whether these loci also play a role in more
common OA subtypes by analyses in much larger datasets. Our pathway
analyses supported the hypothesis of OA being a disease with an early
developmental component.
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2Univ. of Ioannina Sch. of Med., Ioannina, Greece; 3Guy’s and St Thomas’
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Purpose: To ﬁnd novel genes involved in osteoarthritis (OA) by studying
common genetic variation in genes that have previously been identiﬁed
to cause rare skeletal (dysplasia) syndromes, for example achondroplasia
or Stickler syndrome.
Methods: All known genes causing skeletal (dysplasia) syndromes
were selected based 2 criteria: 1. A list of genes selected from the
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International nosology and classiﬁcation of genetic skeletal disorders
and 2. A systematic search in the OMIM (a database of human genes
and genetic disorders). For all selected genes, we explored the common
SNPs arising from the haplotype map of the human genome (HapMap).
A meta-analysis of data from 8 cohorts was performed for these SNPs
for hip OA (5244 cases, 17836 controls) and knee OA (5753 cases, 18498
controls). In addition, these SNPs were studied for association with a
bilateral DIP OA (2007 cases, 3895 controls) and CMC OA (2017 cases,
3885 controls) within the Rotterdam Study-I. An association was declared
signiﬁcant after using FDR correction for multiple testing.
Results: In total, 142 genes involved in skeletal dysplasia syndromes were
selected and 2766 independent SNPs were examined for association
with OA. For knee OA, we observed no associations that passed the
signiﬁcance threshold. For hip OA, an association was found with 2
independent SNPs within the COL11A1 gene (rs1241164, p = 1.5×10−5,
and rs7517682, p = 1.9×10−5). COL11A1 is a minor ﬁbrillar collagen and
adds structure and strength to connective tissue. Rare mutations in this
gene cause some forms of Stickler syndrome. In addition, a low frequent
variant (allele frequency 3%) located in the TBX5-gene was associated
with hip OA (rs2114325, p = 2.7×10−5). TBX5 is a transcription factor
involved in the regulation of developmental processes and mutations
in this gene cause developmental limb disorders. For bilateral CMC-
OA, we found an association with a common variant in the COL10A1
gene (rs11153598, p = 2.3×10−5), mutations in which are known to cause
Schmid type metaphyseal chondrodysplasia.
Conclusions: There is evidence that genes involved in rare skeletal
syndromes are also involved in OA. Further replication is ongoing to
conﬁrm the role of common genetic variation in these genes in OA
susceptibility.
Imaging & Joint Morphometry
357
THE RELATIONSHIP BETWEEN DELAYED GADOLINIUM-ENHANCED
MRI OF MEDIAL TIBIOFEMORAL CARTILAGE (dGEMRIC) AND MEDIAL
MENISCAL PATHOLOGY IN A SAMPLE OF MIDDLE-AGED WOMEN:
A 1-YEAR FOLLOW-UP STUDY USING 3.0 T MRI
M.D. Crema1,2, D.J. Hunter3, D. Burstein4, F.W. Roemer1,5, L. Li6,
N. Krishna4, M.D. Marra1,7, M-P. Hellio Le-Graverand8, A. Guermazi1.
1Boston Univ. Sch. of Med., Boston, MA, USA; 2Inst. of Diagnostic Imaging
(IDI) and Radiology Div., Univ. of Sa˜o Paulo at Ribeira˜o Preto, Ribeira˜o
Preto, Brazil; 3The Univ. of Sydney, Sydney, Australia; 4Harvard Med. Sch.,
Boston, MA, USA; 5Klinikum Augsburg, Augsburg, Germany; 6New England
Baptist Hosp., Boston, MA, USA; 7Inst. of Diagnostic Imaging (IDI), Ribeira˜o
Preto, Brazil; 8Pﬁzer Inc., New London, CT, USA
Purpose: To evaluate the relationship between cartilage compositional
changes assessed by delayed gadolinium-enhanced MRI of medial
tibiofemoral cartilage (dGEMRIC) and medial meniscal pathology in a
sample of middle-aged women, over a 1-year period using 3.0T MRI.
Methods: A total of 148 women aged ≥ 40 years were included in
this longitudinal observational study of knee osteoarthritis (mean age
56.8±8.7; mean BMI 29.3±7.5; radiographic osteoarthritis 37.9%). 3.0T
MRI of the knee was performed at baseline (BL) and 12 months
follow-up (FU). T2-weighted fat-suppressed sequences were acquired
for meniscal morphology assessment. Three-dimensional inversion
recovery-prepared spoiled gradient recalled echo sequences 90 minutes
after intravenous injection of gadolinium (Gd-DTPA2−) were acquired
for dGEMRIC assessment. BL medial meniscal pathology was scored as
follows: 0 (normal), 1 (intra-substance meniscal signal changes), 2 (single
tears), and 3 (complex tears/maceration). Assessment of dGEMRIC was
performed at BL and FU in the central medial femur (cMF), the medial
tibial plateau (MT) and the posterior medial femur (pMF) subregions of
the medial tibiofemoral compartment. Analysis of covariance was used
to examine if BL and FU dGEMRIC values in matched subregions differed
in regard to BL medial meniscal damage severity using normal medial
menisci (grade 0) as the reference group.
Results: At BL, 62 (41.9%) medial menisci were normal (grade 0),
59 (39.9%) had grade 1 changes, 12 (8.1%) had grade 2 lesions, and
15 (10.1%) had grade 3 lesions. The mean dGEMRIC values for each
medial tibiofemoral region and each medial meniscal grade at BL and
FU are displayed in Table 1. At both BL and FU, medial tibiofemoral
compartments with grade 3 meniscal lesions showed signiﬁcantly
decreased dGEMRIC values (less proteoglycan content) at the cMF
subregion compared with values at the cMF subregions of compartments
with normal menisci. Differences in dGEMRIC values at the cMF
subregion between grade 3 vs. grade 0 menisci were −119.1±34.2ms
at BL (p = 0.03) and −120.3±35.2ms at FU (p =0.04). There were no
signiﬁcant differences in dGEMRIC values in compartments with grade 1
meniscal changes or grade 2 meniscal lesions when compared with the
reference group (Table 2).
Conclusions: In this sample of middle-aged women, alterations in
cartilage matrix composition as assessed by dGEMRIC had a signiﬁcant
relationship with high grade damage of the medial meniscus at both
BL and FU assessments. No signiﬁcant changes in cartilage matrix
composition were observed in compartments with only intra-substance
meniscal signal changes or meniscal single tears.
